drugset / Trial / NCT00579995
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
RandomizedParallel-groupOpen-labelDiagnostic
Summary
The purpose of this study is to compare the efficacy of oral N-acetylcysteine and intravenous sodium bicarbonate for the prevention of Contrast-Induced Nephropathy (CIN) after cardiac catheterization.
Timeline
- Start
- 2005-05-01
- Primary completion
- 2010-04-08
- Completion
- 2010-04-08
Outcome
Outcome not reported
Stopped: “Technical measurement problems led to unreliable or uninterpretable data.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 600 mg | Oral |
| Comparator | sodium bicarbonate | Diagnostic / imaging agent | 1 ml | Intravenous |
Indications
No indication recorded.